AVEO Pharmaceuticals, Inc. (AVEO)

[Apophis]

AVEO seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on AVEO’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that AVEO Pharmaceuticals could be a solid choice for investors.